Northstar Ventures: Investment Portfolio & Startup News
Northstar Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
OneClickComply raises £1m seed round led by Mercia Ventures to automate cyber security compliance for businesses
OneClickComply provides a cyber security platform that automates up to 90% of the work involved in achieving standards such as Cyber Essentials, ISO 27001 and SOC 2. The product continuously monitors IT systems, configures security settings and fixes issues to help businesses maintain ongoing compliance.
Dragonfly Advanced Materials secures £1m in funding led by Northstar Ventures to make silica materials cheaper to manufacture
Dragonfly Advanced Materials manufactures silica aerogels, a material that combines low density with strong insulative properties, fire retardancy and water resistance. Its patented process simplifies production and reduces reliance on expensive solvents, making aerogels more accessible to customers in coatings, energy, construction, transport and industrial manufacturing.
Magnitude Biosciences raises £1.3m led by Northstar Ventures to run drug discovery screens in living nematode worms
Magnitude Biosciences is a contract research organisation (CRO) based in Sedgefield, UK, specialising in in vivo drug discovery using C.elegans. Its patented WormGazer® technology and VivoScan™ platform provides rapid, high-quality data on compound efficacy, toxicity, and mechanism of action - helping biotech and pharma companies make better decisions, faster. With over 120 projects delivered, Magnitude is trusted by clients in drug discovery, health and nutrition, and ageing biology.
Land Digital secures £700k in funding led by Northstar Ventures for barrier-free tolling and parking technology
Land Digital builds a configurable back-office platform for barrier-free tolling, parking and transport operations, using Automatic Number Plate Recognition (ANPR), data processing and AI. The platform helps transport operators optimise pricing, improve throughput and compliance, and cut reliance on manual processes and on-site infrastructure.
PolyBox raises £700k in funding to automate data reporting in real-time for marketing teams
PolyBox provides a real-time platform that brings market data together for marketing teams and turns it into reports, forecasts and models. Built by marketers for marketers, the platform is designed to be used without in-depth technological knowledge.
Gnosis Health raises £1.1m led by SFC Capital to build digital healthcare assistant for Parkinson's disease
Gnosis Health is building MAXine, a digital healthcare assistant for Parkinson’s disease. MAXine uses data from wearables, patient reported outcomes and behavioural patterns to support patient self-management and communication with care teams.
H2CHP raises £1.5m from Northstar Ventures and Blackfinch Ventures for fuel-flexible generators built for changing power demands
H2CHP develops distributed electric generators that can run on hydrogen, ammonia, biofuels and e-fuels. The technology is designed for applications including data centres, ports, construction sites, backup power systems and microgrids, while reducing reliance on permanent magnets and rare-earth materials.
NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.
Northstar Ventures lead £1.6m funding round into AI-powered customer feedback analysis provider Wordnerds
Wordnerds uses AI and behavioural science to analyse large volumes of customer feedback, turning unstructured data into real-time insights that organisations can act on quickly.
Newcells raises further £1.2m funding for laboratory models that speed up drug development
Newcells develops advanced human tissue models that replace animal testing in drug development, helping pharmaceutical companies predict safety and efficacy more accurately before clinical trials.
More venture news
- 1 Oct 2026
RevnuRevnu secures a £2.3m seed round led by PXN Ventures to help early-stage companies automate growth
SeedMarketing - 24 Sept 2026
IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth - 23 Sept 2026
OneClickComplyOneClickComply raises £1m seed round led by Mercia Ventures to automate cyber security compliance for businesses
SeedCybersecurity